DAVA vs. DOCS, PRFT, PRO, FORTY, TWKS, CINT, PERI, RMBL, TBRG, and ISSC
Should you be buying Endava stock or one of its competitors? The main competitors of Endava include Doximity (DOCS), Perficient (PRFT), PROS (PRO), Formula Systems (1985) (FORTY), Thoughtworks (TWKS), CI&T (CINT), Perion Network (PERI), RumbleOn (RMBL), TruBridge (TBRG), and Innovative Solutions and Support (ISSC). These companies are all part of the "custom computer programming services" industry.
Endava (NYSE:DAVA) and Doximity (NASDAQ:DOCS) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, community ranking, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.
Doximity has lower revenue, but higher earnings than Endava. Endava is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.
In the previous week, Doximity had 14 more articles in the media than Endava. MarketBeat recorded 18 mentions for Doximity and 4 mentions for Endava. Endava's average media sentiment score of 0.74 beat Doximity's score of 0.10 indicating that Endava is being referred to more favorably in the media.
Doximity has a net margin of 31.04% compared to Endava's net margin of 5.69%. Doximity's return on equity of 17.44% beat Endava's return on equity.
Endava received 153 more outperform votes than Doximity when rated by MarketBeat users. Likewise, 57.67% of users gave Endava an outperform vote while only 41.32% of users gave Doximity an outperform vote.
Endava currently has a consensus price target of $46.41, indicating a potential upside of 72.46%. Doximity has a consensus price target of $28.73, indicating a potential downside of 1.62%. Given Endava's stronger consensus rating and higher probable upside, equities research analysts plainly believe Endava is more favorable than Doximity.
62.2% of Endava shares are owned by institutional investors. Comparatively, 87.2% of Doximity shares are owned by institutional investors. 18.8% of Endava shares are owned by company insiders. Comparatively, 39.4% of Doximity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Endava has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500. Comparatively, Doximity has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500.
Summary
Doximity beats Endava on 10 of the 18 factors compared between the two stocks.
Get Endava News Delivered to You Automatically
Sign up to receive the latest news and ratings for DAVA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DAVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
